Vimarsana
Biggest News Aggregation in the World

Page 10 - Risk Evaluation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Risk Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Risk Evaluation Today - Breaking & Trending Today

Drug Lobby Dealt Setback Over Arkansas Contract Pharmacy Law - Vimarsana News

Drug Lobby Dealt Setback Over Arkansas Contract Pharmacy Law

An Arkansas law prohibiting drugmakers from refusing to supply discounted drugs to certain pharmacies is constitutional, a federal appeals court ruled Tuesday.

REMS Program Resources for Clinicians - Vimarsana News

REMS Program Resources for Clinicians

An expert cardiologist discusses the importance of healthcare provider education and finding resources around the REMS program.

Chemotherapy-Induced Psychosis in an Adolescent - Vimarsana News

Chemotherapy-Induced Psychosis in an Adolescent

Check out this case study to learn more about how viral infections might play a role in triggering psychotic disorders.

Role of Mavacamten in Treating oHCM - Vimarsana News

Role of Mavacamten in Treating oHCM

James L. Januzzi, MD, comments on mavacamten as the first approved cardiac myosin inhibitor for oHCM, balancing the increased risk of heart failure with the medication, and the role of the REMS program.

Many Older Adults Don't Receive Palliative Care Before Death - Vimarsana News

Many Older Adults Don't Receive Palliative Care Before Death

A tool that estimates mortality risk could help clinicians determine which patients receiving home care are close to death and might benefit from palliative care.